Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 9, 2022
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
[ Mon, May 09th 2022
] - WOPRAI
Jonathan Chang Maintained (ADAP) at Hold with Increased Target to $3 on, May 9th, 2022
Jonathan Chang of SVB Leerink, Maintained "Adaptimmune Therapeutics plc" (ADAP) at Hold with Increased Target from $2 to $3 on, May 9th, 2022.
Jonathan, nor any peers, have made any analyst calls on ADAP in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30